Renovia, a developer of technology to treat pelvic floor disorders, raised money in an Ascension Ventures-led round backed by OSF Ventures.

Ascenta spinoff Ascentage Pharma, which also counts 3SBio and Unity Biotechnology as backers, has filed to float having raised about $235m in funding.

Principia Biopharma, whose drug discovery platform is based on research at UCSF, has filed for an $86.3m initial public offering having raised $50m earlier this month.

Ali Health will buy a 14.5% stake in retailer Guizhou Ensure Chain Pharmacy for $61.3m and has the option to increase it to 25%.

GlaxoSmithKline-backed Principia Biopharma has filed for an $86.3m initial public offering having raised $50m earlier this month.

The AstraZeneca antibacterial medicine spinout aims to raise $86.3m in an initial public offering that could also herald an exit for Novo.

The GV-backed care provider is in late-stage talks for a $200m investment by Carlyle Group alongside a $100m secondary share purchase.

Bumble Fund has secured $1m in capital commitments from its parent company and will invest up to $250,000 in female-founded startups.

Tasly-backed immunotherapy developer I-Mab Biopharma is reportedly eyeing a Hong Kong flotation having recently raised $220m in funding.